Galectin Therapeutics Inc. (GALT) Financials

$1.49

north_east
$0.02 (1.36%)
Day's range
$1.45
Day's range
$1.53
$0$0-$10M-$10M-$20M-$20M-$30M-$30M-$40M-$40M-$50M-$50MEarning201720172018201820192019202020202021202120222022202320235%5%4%4%3%3%2%2%1%1%0%0%Profit Margin
Profit Margin
Revenue
Earnings

GALT Income statement / Annual

Last year (2023), Galectin Therapeutics Inc.'s total revenue was $0.00, and the percentage change from the previous year is not available. In 2023, Galectin Therapeutics Inc.'s net income was -$41.07 M. See Galectin Therapeutics Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015 FY-2014
Period Ended 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Operating Revenue $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Cost of Revenue $33,000.00 $32,000.00 $41,000.00 $36,000.00 $35,000.00 $0.00 $1,000.00 $7,000.00 $7,000.00 $0.00
Gross Profit -$33,000.00 -$32,000.00 -$41,000.00 -$36,000.00 -$35,000.00 $0.00 -$1,000.00 -$7,000.00 -$7,000.00 $0.00
Gross Profit Ratio 0 0 0 0 0 0 0 0 0 0
Research and Development Expenses $32.13 M $31.74 M $23.82 M $17.98 M $7.47 M $6.47 M $11.72 M $15.33 M $13.11 M $8.43 M
General & Administrative Expenses $5.90 M $6.62 M $6.36 M $5.47 M $5.97 M $7.13 M $4.53 M $6.16 M $6.97 M $7.01 M
Selling & Marketing Expenses $44,000.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $5.94 M $6.62 M $6.36 M $5.47 M $5.97 M $7.13 M $4.53 M $6.16 M $6.97 M $7.01 M
Other Expenses -$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Operating Expenses $38.07 M $38.35 M $30.18 M $23.44 M $13.44 M $13.60 M $16.25 M $21.48 M $20.08 M $15.43 M
Cost And Expenses $38.07 M $38.35 M $30.18 M $23.44 M $13.44 M $13.60 M $16.25 M $21.48 M $20.08 M $15.43 M
Interest Income $0.00 $52,000.00 $3,000.00 $66,000.00 $231,000.00 $38,000.00 $24,000.00 $45,000.00 $52,000.00 $42,000.00
Interest Expense $2.56 M $1.03 M $489,000.00 $87,000.00 $87,000.00 $336,000.00 $12,000.00 $0.00 $0.00 $0.00
Depreciation & Amortization $38.07 M $32,000.00 $41,000.00 $36,000.00 $35,000.00 $1,000.00 $1,000.00 $7,000.00 $7,000.00 $10,000.00
EBITDA -$202,000.00 -$37.71 M -$30.00 M -$23.34 M -$13.17 M -$13.56 M -$16.23 M -$21.47 M -$20.07 M -$15.78 M
EBITDA Ratio 0 0 0 0 0 0 0 0 0 0
Operating Income Ratio 0 0 0 0 0 0 0 0 0 0
Total Other Income/Expenses Net -$2.99 M -$424,000.00 -$348,000.00 -$21,000.00 $144,000.00 -$298,000.00 $12,000.00 $45,000.00 $52,000.00 -$358,000.00
Income Before Tax -$41.07 M -$38.78 M -$30.53 M -$23.47 M -$13.29 M -$13.90 M -$16.24 M -$21.44 M -$20.03 M -$15.79 M
Income Before Tax Ratio 0 0 0 0 0 0 0 0 0 0
Income Tax Expense $0.00 $424,000.00 $448,000.00 $51,000.00 $87,000.00 -$123,141.00 $24,000.00 $0.00 $0.00 -$52,000.00
Net Income -$41.07 M -$39.20 M -$30.98 M -$23.52 M -$13.38 M -$13.90 M -$16.24 M -$21.44 M -$20.03 M -$15.79 M
Net Income Ratio 0 0 0 0 0 0 0 0 0 0
EPS -0.74 -0.66 -0.53 -0.41 -0.26 -0.35 -0.46 -0.73 -0.83 -0.72
EPS Diluted -0.74 -0.66 -0.53 -0.41 -0.26 -0.35 -0.46 -0.73 -0.83 -0.72
Weighted Average Shares Out $60.16 M $59.39 M $58.53 M $57.03 M $52.24 M $39.41 M $35.52 M $29.22 M $24.12 M $21.85 M
Weighted Average Shares Out Diluted $60.16 M $59.39 M $58.53 M $57.03 M $52.24 M $39.41 M $35.52 M $29.22 M $24.12 M $21.85 M
Link